单位：[1]Clinical Epidemiology andEBMUnit, Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, Mainland China临床科室国家中心肝病分中心首都医科大学附属北京友谊医院[2]Genomics Research Center, Academia Sinica, Taipei, Taiwan
第一作者单位：[1]Clinical Epidemiology andEBMUnit, Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, Mainland China
通讯作者：
通讯机构：[2]Genomics Research Center, Academia Sinica, Taipei, Taiwan[*1]Genomics Research Center, Academia Sinica, Nankang, Taipei 11529, Taiwan
推荐引用方式(GB/T 7714)：
Kong Yuanyuan,Jia Jidong,Yang Hwai-I.Lower Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B[J].JAMA ONCOLOGY.2019,5(6):915-916.doi:10.1001/jamaoncol.2019.0647.
APA：
Kong, Yuanyuan,Jia, Jidong&Yang, Hwai-I.(2019).Lower Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B.JAMA ONCOLOGY,5,(6)
MLA：
Kong, Yuanyuan,et al."Lower Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B".JAMA ONCOLOGY 5..6(2019):915-916
医学